Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

NCT: NCT04559945 · COMPLETED

NCT IDNCT04559945
StatusCOMPLETED
Start Date2020-11-13
Completion2023-09-15

Brief Summary

prospective, non-randomized, multi-center, international clinical study is designed to confirm the safety and effectiveness of the Aveir LP System in a subject population indicated for a VVI(R) pacemaker.

Frequently Asked Questions

What is The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System?

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System is a clinical trial registered under NCT04559945. Current status: COMPLETED.

What is the status of NCT04559945?

The current status of NCT04559945 (The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System) is: COMPLETED.

When did The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System start?

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System started on 2020-11-13.

Related Devices

PMA P150033 Leadless pacemaker Medtronic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑